➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Express Scripts
Dow
Boehringer Ingelheim
Mallinckrodt

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Drugs in MeSH Category Parasympatholytics


Email this page to a colleague

« Back to Dashboard

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride INJECTABLE;INJECTION 210979-001 Jul 2, 2018 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Epic Pharma Llc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 072266-001 Feb 27, 1989 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Rafa Labs Ltd ATROPINE (AUTOINJECTOR) atropine SOLUTION;INTRAMUSCULAR 212319-001 Jul 9, 2018 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Akorn AKPENTOLATE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 040165-001 Jan 13, 1997 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pioneer Pharms DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 089361-001 Jan 10, 1989 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Usl Pharma BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 089212-001 Jun 14, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Try it Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Colorcon
Merck
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group